2 assets in Endocrine Gland Neoplasm
Therapeutic assets addressing Endocrine Gland Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Teonanacatl Endocrine Gland Neoplasm | University Health Network, Toronto | P2 | CCC (53) |